Warp Sciences debuts with $215M Series A from ex-OpenAI science head Kevin Weil
- Warp Sciences has emerged from stealth with a $215 million Series A.
- It was founded by Kevin Weil, formerly OpenAI's head of science, with technology veterans.
- It aims to use AI to help pharma companies make the building blocks for new drugs.
💡 Points
A $215M first round for a company that has not yet shown a product shows how much capital is chasing AI-for-chemistry, and focusing on building blocks rather than drug candidates avoids the clinical risk that sinks most AI biotechs. Its customers and data advantage are the open questions; treat the headline number as a bet on the team.
Warp Sciences emerges from stealth, founded by ex-OpenAI science chief and tech veterans ↗